New Life Biologics, a pioneering biotechnology company, is excited to announce its participation in the upcoming BioProcess International US West Expo, a premier event dedicated to advancing bioprocessing technologies and accelerating the speed to market for next-generation biologics.
The Expo, renowned for its focus on innovative strategies and technologies, aims to improve process efficiencies and maintain product quality across all phases of bioprocessing. It serves as a vital platform for professionals in the biopharmaceutical industry to access the latest developments in the production of monoclonal antibodies (mAbs), vaccines, and cell & gene therapy products.
Attendees will have the unique opportunity to learn from the brightest minds in bioprocessing, with speakers representing top scientists from leading biopharmaceutical companies around the world. The scientific agenda is packed with novel insights from recent case studies and new data presentations designed to accelerate speed and lower costs across all phases of bioprocessing.
New Life Biologics is poised to make a significant impact at the Expo, showcasing its cutting-edge technologies and premium-grade products, including plasma fractions and animal extract products tailored for life science research, diagnostics, and biopharmaceuticals. The company’s commitment to leveraging the raw power of nature for the benefit of people and the planet aligns perfectly with the Expo’s goals of improving the speed, lowering the cost, and increasing the quality and safety of biologics development.
“We are thrilled to be part of the BioProcess International US West Expo and look forward to sharing our innovative solutions with the global biopharmaceutical community,” said Randy Fitzgerald, CEO, New Life Biologics. “Our participation underscores our dedication to advancing biotechnology for a more sustainable and healthier future.”
For more information about New Life Biologics and our participation in the Expo, please visit www.informaconnect.com/bpi-west.
